ADMA Biologics

YTD

ALL

Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate.

CEO

Adam S. Grossman

CEOAdam S. Grossman

Employees

685

Employees685

Headquarters

Ramsey, New Jersey

HeadquartersRamsey, New Jersey

Founded

2004

Founded2004

Employees

685

Employees685

ADMA Key Statistics

Market cap

3.72B

Market cap3.72B

Price-Earnings ratio

18.47

Price-Earnings ratio18.47

Dividend yield

—

Dividend yield—

Average volume

3.22M

Average volume3.22M

High today

$15.96

High today$15.96

Low today

$15.40

Low today$15.40

Open price

$15.69

Open price$15.69

Volume

2.68M

Volume2.68M

52 Week high

$25.67

52 Week high$25.67

52 Week low

$13.50

52 Week low$13.50

ADMA News

Simply Wall St 4d

ADMA Biologics: Assessing Valuation as Investors Await Key Healthcare Conference Updates

ADMA Biologics (ADMA) has recently captured investor attention with its upcoming presentation at the Morgan Stanley 23rd Annual Global Healthcare Conference in...

Simply Wall St 7d

Could ADMA Biologics’ Conference Spotlight Reveal New Directions for Its Innovation Strategy?

ADMA Biologics presented at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, at the Sheraton New York Times Square, highlightin...

People also own

Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.